Year: 2024

The Japanese carmaker cut its global sales forecast, projecting a decline in all major markets, after its third-quarter profit missed expectations.

AstraZeneca reported core earnings for the fourth quarter just short of consensus, but said it expected double-digit percentage growth in 2024.

British American Tobacco reported full-year adjusted profits below consensus but backed its growth forecast for 2024, and cautioned that investment to strengthen its U.S. business would weight its performance to the second half.

Maersk suspended its share buyback program as it moved to preserve cash, with uncertainty surrounding disruption in the Red Sea and as industry overcapacity continued to drag on freight rates.

Gucci owner Kering warned that recurring operating income in 2024 would fall short of last year’s figure, particularly in the first half, with investments and a normalization of sales growth across the sector seen weighing on its profits.